NextCell Pharma

NextCell Pharma is an innovative biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Diseases such as Diabetes type 1.

NextCell is focusing on research and development of novel stem cell therapies and is also running a tissue establishment and primary biobank, classified as healthcare provider. ProTrans is based on NextCell patent pending Selection Algorithm. Further, NextCell runs Cellaviva, Nordic’s largest private stem cell bank, approved by IVO.